SMMT earnings date and last-quarter result: next report 2026-07-23, last quarter beat, P/E -10.53. Updated 2026-07-23.
Summit Therapeutics (SMMT) Research Hub
Summit Therapeutics (SMMT) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 14.5 USD (-6.27%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -10.53, market cap 11.53B. This hub links to the full technical, earnings and options research available for SMMT.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 14.5 USD (-6.27%) |
| 52-week range | 12.07 USD – 19.09 USD |
| Trend regime | Range |
| 14-day RSI | 33.1 (Bearish) |
| Trailing P/E | -10.53 |
| Market cap | 11.53B |
| Dividend yield | 0.00% |
| Next earnings | 2026-07-23 |
Available research for SMMT
Covered Call on SMMT: how it works, illustrative setup around the real 14.5 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on SMMT: how it works, illustrative setup around the real 14.5 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on SMMT: how it works, illustrative setup around the real 14.5 USD price, max profit/loss, breakeven and when to use it. Educational.
SMMT technical analysis: range, last 14.5 USD, RSI 33.1, 52w range 12.07 USD–19.09 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is SMMT in?
Summit Therapeutics (SMMT) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is SMMT in an uptrend or downtrend?
As of 2026-10-26, SMMT is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is SMMT's trailing P/E ratio?
SMMT's trailing P/E is -10.53, with a market cap of 11.53B. See the earnings research page for full valuation detail.
When does SMMT next report earnings?
SMMT is next scheduled to report earnings on 2026-07-23.